Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04309123 · ClinicalTrials.gov registry record · NA

Pilot Study of TransAeris® System in Surgical Patients at Risk of Prolonged Mechanical Ventilation

A NA study, sponsored by Synapse Biomedical.

Completed
Registry status
NA
Development phase
40
Enrollment target

NCT04309123: Completed NA study, sponsored by Synapse Biomedical.

NCT04309123 is a NA study that has completed, run by Synapse Biomedical. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04309123, a NA study, has completed, sponsored by Synapse Biomedical.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target

Study Summary

This study will be conducted as a pilot trial of the TransAeris system for the prevention and treatment of ventilator-induced diaphragm dysfunction (VIDD) in patients identified prior to surgery to be at greater risk of prolonged mechanical ventilation (PMV).

Primary Outcome

Incidence of Serious Device Related Adverse Events

Interventions

  • DEVICE TransAeris System

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2020-03-30
Est. Completion 2021-04-01
Phase NA
Synapse Biomedical

4 total trials

What the finished NCT04309123 record still lists

NCT04309123 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 1 intervention - of which TransAeris System is the first listed.

NCT04309123 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04309123 about?

NCT04309123 is a clinical study titled "Pilot Study of TransAeris® System in Surgical Patients at Risk of Prolonged Mechanical Ventilation". This study will be conducted as a pilot trial of the TransAeris system for the prevention and treatment of ventilator-induced diaphragm dysfunction (VIDD) in patients identified prior to surgery to be at greater risk of prolonged mechanical ventilation (PMV).

What is the current status of trial NCT04309123?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2020-03-30. Estimated completion is 2021-04-01.

What interventions are being tested in trial NCT04309123?

The interventions under investigation include: TransAeris System (DEVICE).

Who is sponsoring clinical trial NCT04309123?

This trial is sponsored by Synapse Biomedical, which has 4 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04309123's enrollment target sits among peer trials

40 1447th of 2000 higher than 465 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04309123, the US trial registry maintained by the National Library of Medicine. NCT04309123 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.